熱門資訊> 正文
NovaBay Pharmaceuticals将以950万美元出售Avenova资产
2024-09-20 20:07
- NovaBay Pharmaceuticals (NYSE:NBY) said it will sell the assets of the Avenova brand for $9.5M in cash.
- The firm has signed an agreement with PRN Physician Recommended Nutriceuticals for the deal.
- The deal is expected to close in the fourth quarter of the year.
More on NovaBay
- NovaBay Pharmaceuticals, Inc. (NBY) Q2 2024 Earnings Call Transcript
- NovaBay Pharmaceuticals announces pricing of $3.5M underwritten offering
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
